Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer

With the rapid development and wide application of next generation sequencing (NGS) technology, a series of researches have revealed that concurrent genetic alterations play an important role in the response and resistance of epidermal growth factor receptor (EGFR)-mutant NSCLC to EGFR-tyrosine kina...

Full description

Bibliographic Details
Main Authors: Rong WANG, Sisi PAN, Xia SONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
tp53
epidermal growth factor receptor
co-mutation
therapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.06

Similar Items